CO.DON AG

  • WKN: A1K022
  • ISIN: DE000A1K0227
  • Land: Deutschland

Nachricht vom 22.05.2019 | 19:49

CO.DON AG: Capital increase completed successfully

DGAP-News: CO.DON AG / Key word(s): Capital Increase

22.05.2019 / 19:49
The issuer is solely responsible for the content of this announcement.


CO.DON AG - Capital increase completed successfully

Berlin / Teltow, 22 May 2019 - CO.DON Aktiengesellschaft, Berlin (DE000A1K0227) successfully placed its cash capital increase with subscription rights from authorised capital by issuing 1,056,568 new shares today. The gross issue proceeds amount to some EUR 4.3 million.

After entry in the commercial register the company's share capital is therefore increased by EUR 1,056,568.00 from EUR 20,331,382.00 to EUR 21,387,950.00 by the issue of 1,056,568 new bearer shares, each representing EUR 1.00 of the company's share capital.

The new shares are to be admitted for trading on the regulated market (General Standard) of Frankfurt Stock Exchange without a prospectus and are expected to be listed on 24 June 2019.

"My thanks go to our shareholders for their great interest in the capital increase. It is an expression of their confidence in the business case of CO.DON AG and an important acknowledgement of our progress on the way towards marketing our main product across the EU. This funding enables us to step up our European expansion once again and to take the first steps towards extending our portfolio", said Ralf Jakobs, CEO of CO.DON AG.

Lead manager for the cash capital increase was Baader Bank Aktiengesellschaft, Unterschleißheim.

CO.DON AG develops, produces and markets autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product that uses only the patient's own cartilage cells ("autologous chondrocytes"). CO.DON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated. In July 2017 we received marketing authorisation for the advanced therapy medicinal product Spherox from the European Medicines Agency. The shares in CO.DON AG are listed on the Frankfurt Stock Exchange (ISIN: DE000A1K0227). Executive Board: Ralf M. Jakobs.
Further information is available from www.codon.de

Investor Relations and Press Contact:
Matthias Meißner, M.A.
Corporate communications / IR / PR
Tel. +49 (0)30 240352330
Fax +49 (0)30 240352309
Email: ir@codon.de



22.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Interview im Fokus

HanseYachts: „Der ideale Zeitpunkt für den Kauf“

Die Übernahme des Katamaran-Herstellers Privilège bringt die HanseYachts AG dem Umsatzziel von 200 Mio. Euro einen bedeutenden Schritt näher. „Der Katamaran-Markt ist das derzeit am stärksten wachsende Segment im Yacht-Geschäft. Privilège ist weltweit in Preis und Qualität die Nummer eins“, so CEO Dr. Jens Gerhardt. Zudem sei der Deal ein wichtiger Faktor, um die EBITDA-Marge auf 10 bis 12 % zu steigern. Im Financial.de-Interview spricht der Konzernlenker über die aktuellsten Trends im Yacht-Geschäft, die laufende Barkapitalerhöhung sowie die Weltpremieren in Cannes.

GBC-Fokusbox

Fonds Research 2019: S.E.A. Asian High Yield Bond bietet attraktive Investitionschance

Auch 2019 hat die GBC AG unter der Vielzahl an Publikumsfonds neun „Fonds Champions“ herausgefiltert. Darunter auch den S.E.A. Asian High Yield Bond (ISIN: LU1138637738), der eine gute Anlagechance anbietet mit einer Strategie, die kaum reproduzierbar ist. Insbesondere vor dem Hintergrund des anhaltenden Niedrigzinsniveaus sehen wir den Anleihefonds als äußerst attraktive Investitionschance, um nachhaltige und volatilitätsarme Renditen zu erzielen. Wir haben den S.E.A. Asian High Yield Bond mit 4 von 5 Falken eingestuft.

Aktueller Webcast

SeaChange Corporation

Second Quarter 2020 Earnings Conference Call

29. August 2019

Aktuelle Research-Studie

HELMA Eigenheimbau AG

Original-Research: HELMA Eigenheimbau AG (von GBC AG): Kaufen

22. August 2019